Upstream Bio股价因重度哮喘二期数据上涨8%（UPB:NASDAQ）
· seekingalpha.com
Upstream Bio (UPB) 在公布重度哮喘药物vere kitug的二期VALIANT数据后上涨8%。
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
If you have an ad-blocker enabled you may be blocked from ...